bioscience

See the following -

NIST Issues Call For Developing -- And Using -- Consensus Standards To Ensure The Quality Of Cell Lines

Press Release | National Institute Of Standards And Technology (NIST) | June 14, 2016

Mainstays of biomedical research, permanent lines of cloned cells are used to study the biology of health and disease and to test prospective medical therapies. Yet, all too often, these apparent pillars of bioscience and biotechnology crumble because they are crafted from faulty starting materials: misidentified or cross-contaminated cell lines. Writing in the June 2016 issue of PLOS Biology, scientists from the National Institute of Standards and Technology (NIST) call for "community action" to assemble a "comprehensive toolkit for assuring the quality of cell lines," employed at the start of every study.

Redefining Medicine With Apps And iPads

Katie Hafner | New York Times | October 8, 2012

The history of medicine is defined by advances born of bioscience. But never before has it been driven to this degree by digital technology... Read More »

Unlocking Chemistry: It's Time To Make The Subject As Open As Bioscience

Peter Murray-Rust | The Guardian | January 6, 2014

Now that millions of patented compounds are open information, chemistry has a chance to catch up, says Peter Murray-Rust Read More »

Why Open Source Drug Discovery Needs A “Champion”

Sean Ekins | Collaborative Chemistry | April 5, 2013

Yesterday I attended the Southeast Venture Philanthropy Summit held in Chapel Hill. Attendees included VC, philanthropy types, disease foundations (big and small), bioscience organizations, scientists from all over the country... Read More »